InChI: | InChI=1/C22H28NO3.CH4O4S/c1-23(2)16-10-9-15-20(23)17-26-21(24)22(25,18-11-5-3-6-12-18)19-13-7-4-8-14-19;1-5-6(2,3)4/h3-8,11-14,20,25H,9-10,15-17H2,1-2H3;1H3,(H,2,3,4)/q+1;/p-1 |
Specification: |
CG201 is such an improved formulation, which has been brought through preclinical evaluation studies in preparation for clinical trials in cancer patients.CG201 represents a great improvement in immunopotency over older anti-hCG vaccine formulations, yielding much higher levels of anti-hCG antibodies than possible with previous formulations. Its Synonyms are 2-(Hydroxymethyl)-1,1-dimethylpiperidinium methyl sulfate benzilate ; Acabel ; Benzilic acid ester with 2-(hydroxymethyl)-1,1-dimethylpiperidinium methyl sulfate ; Benzilsaeure-(N,N-dimethyl-2-hydroxymethyl-piperidinium)-ester-methylsulfat ; Bevonii metilsulfas ; Bevonium methyl sulfate ; Bevonium methylsulphate ; Bevonium metilsulfate ; Ester d'acide benzilique et du 1-methylsulfate de 1,1-dimethyl-(2-hydroxymethyl)piperidinium ; Ester del acido bencilico del 1,1-dimetil-2-oximetil-piperidinio-metilsulfato ; Metilsulfate de bevonium ; Metilsulfato de bevonio ; Piperidinium, 2-(hydroxymethyl)-1,1-dimethyl-, methyl sulfate, benzilate ; Piribenzil methyl sulfate ; alpha-Phenylmandelic acid N,N-dimethylpiperidinium-2-methyl ester methylsulfate .
|